MedTrace Logo

Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic Diversion (BPD)- Duodenal Switch for Superobesity

NCT00327912 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-02-02

No results posted yet for this study

Summary

The purpose of this study is to compare the outcome in a broad perspective after laparoscopic Roux-en-Y gastric bypass and laparoscopic BPD-duodenal switch in the treatment of superobesity (body mass index \[BMI\] \> 50 kg/m2).

Conditions

Interventions

PROCEDURE

Laparoscopic Biliopancreatic diversion with Duodenal switch

PROCEDURE

Laparoscopic Roux-en-Y Gastric Bypass

Sponsors & Collaborators

  • Helse Sor-Ost

    collaborator OTHER_GOV

  • Göteborg University

    lead OTHER

Principal Investigators

  • Hans H Lönroth, MD, PhD · Sahlgrenska University Hospital

  • Tom Mala, MD, PhD · Aker University Hospital, Oslo, Norway

  • Jon Kristinsson, MD, PhD · Aker University Hospital, Oslo, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Norway
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00327912 on ClinicalTrials.gov